Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 8, 2001 - Issue 3
16
Views
13
CrossRef citations to date
0
Altmetric
Original Article

The in-vitro influence of serum amyloid A isoforms on enzymes that regulate the balance between esterified and un-esterified cholesterol

, , , &
Pages 169-181 | Received 06 Oct 2000, Published online: 06 Jul 2009

References

  • Fantone J C, Ward P A. Inflammation. Pathology, E. Rubin, J. Farber. Lippincott, Philadelphia 1994; 32–67
  • Macchia T, Mancinelli R, Barbini D A, Taggi F, Avico U, Cantafora A. Determination of membrane cholesterol in normal and pathological red blood cells. Clin Chim Acta 1991; 199: 59–67
  • Cooper R A. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. J Supramol Struct 1978; 8: 413–430
  • Uhlar C M, Black I L, Shields D C, Brack C M, Schreiber G, Whitehead A S. Wallaby serum amyloid A protein: cDNA cloning, sequence and evolutionary analysis. Scand J Immunol 1996; 43: 271–276
  • Uhlar C M, Burgess C J, Sharp P M, Whitehead A S. Evolution of the Serum Amyloid A (SAA) Protein Super-family. Genomics 1994; 19: 228–235
  • Jensen L, Hiney E. MP, Shields D C, Uhlar C M, Lindsay A J, Whitehead A S. Acute phase proteins in salmo-nids-Evolutionary analyses and acute phase response. J Immunol 1997; 158: 384–392
  • Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precurser SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985; 21: 283–287
  • Tape C, Tan R, Nesheim M, Kisilevsky R. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol 1988; 28: 317–324
  • Hoffman J S, Ericsson L H, Eriksen N, Walsh K A, Benditt E P. Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 1984; 159: 641–646
  • Liepnieks J J, Kluve-Beckerman B, Benson M D. Characterization of amyloid A protein in human secondary amyloidosis: The predominant deposition of serum amyloid Al. Biochim Biophys Acta 1995; 1270: 81–86
  • Tatsuta E, Shirahama T, Sipe J D, Skinner M, Cohen A S. Kinetics of SAP and SAA production by cultured mouse liver cells. Ann N Y Acad Sci 1982; 389: 467–470
  • Tatsuta E, Sipe J D, Shirahama T, Skinner M, Cohen A S. Different regulatory mechanisms for serum amyloid A and serum amyloid P by cultured mouse hepatocytes. J Biol Chem 1983; 258: 5414–5418
  • Kushner I, Rzewnicki D L. The Acute Phase Respose: General Aspects. Clinical Rheumatology: Vol. 8 No. 3, Reactive Amyloidosis and the Acute Phase Response, G. Husby. Bailliere Tindall, London 1994; 513–530
  • Ray B K, Ray A. Induction of serum amyloid A (SAA) gene by SAA-activating sequence-binding factor (SAF) in monocyte/macrophage cells-Evidence for a functional synergy between SAF and Spl. J Biol Chem 1997; 272: 28948–28953
  • Ray B K, Ray A. Functional NF-kappa-B Element in Rabbit Serum Amyloid-A Gene and Its Role in Acute Phase Induction. Biochem Biophys Res Commun 1993; 193: 1159–1167
  • Ray A, Schatten H, Ray B K. Activation of Spl and its functional co-operation with serum amyloid A-acti-vating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem 1999; 274: 4300–4308
  • Ray A, Hannink M, Ray B K. Concerted participation of NF-KB and C/EBP heteromer in lipopolysaccharide induction of serum amyloid a gene expression in liver. J Biol Chem 1995; 270: 7365–7374
  • Li X X, Liao W SL. Cooperative Effects of C/EBP-Like and NFchiB-Like Binding Sites on Rat Serum Amyloid Al Gene Expression in Liver Cells. Nucl Acid Res 1992; 20: 4765–4772
  • Edbrooke M R, Foldi J, Cheshire J K, Li F, Faulkes D J, Woo P. Constitutive and NF-kappaB Like Proteins in the Regulation of the Serum Amyloid-A Gene by Interleukin-I. Cytokine 1991; 3: 380–388
  • Lowell C A, Stearman R S, Morrow J F. Transcrip-tional regulation of serum amyloid A gene expression. J Biol Chem 1986; 261: 8453–8461
  • Brissette L, Young I, Narindrasorasak S, Kisilevsky R, Deeley R. Differential Induction of the Serum Amyloid-A Gene Family in Response to an Inflammatory Agent and to Amyloid-Enhancing Factor. JBiol Chem 1989; 264: 19327–19332
  • Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid 1994; 1: 118–137
  • Hoffman J S, Benditt E P. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982; 257: 10518–10522
  • Coetzee G A, Strachan A F, van der Westhuyzen D R, Hoppe H C, Jeenah M S, de Beer F C. Serum amyloid A-containing human high density lipoprotein 3: Density, size, and apolipoprotein composition. J Biol Chem 1986; 261: 9644–9651
  • Clifton P M, Mackinnon A M, Barter P J. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocar-dial infarction. J Lipid Res 1985; 26: 1389–1398
  • Cabana V G, Siegel J N, Sabessin S M. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30: 39–49
  • van der Westhuyzen D R, Coetzee G A, de Beer F C. Serum amyloid A protein in plasma: characteristics of acute phase HDL. Amyloidosis, J. Marrink, M. H. van Rijswijk. Martinus Nijhoff, Dordrecht 1986; 115–125
  • Husebekk A, Skogen B, Husby G. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoproteins (HDL). Displacement of SAA from the HDL-SAA complex by apoA-I and apoA-II. Scand J Immtinol 1987; 25: 375–382
  • Benson M D, Aldo-Benson M A, Shirahama T, Borel Y, Cohen A S. Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med 1975; 142: 236–241
  • Benson M D, Aldo-Benson M. Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol 1979; 122: 2077–2082
  • Benson M D, Aldo-Benson M A. SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Inmunol 1982; 128: 2390–2392
  • Badolato R, Wang J M, Murphy W J, Lloyd A R, Michiel D F, Bausserman L L, Kelvin D J, Oppenheim J J. Serum amyloid A is achemoattractant: Induction of migration, adhesion. and tissue infiltration of monocytes and polymor-phonuclear leukocytes. J Exp, Med 1994; 180: 203–209
  • Xu L L, Badolato R, Murphy W J, Longo D L, Anver M, Hale S, Oppenheim J J, Wang J M. A novel biologic function of serum amyloid A-Induction of T lymphocyte migration and adhesion. J Immunol 1995; 155: 1184–1190
  • Badolato R, Johnston J A, Wang J M, McVicar D, Xu L L, Oppenheim J J, Kelvin D J. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 1995; 155: 4004–4010
  • Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Mekori Y A. Mast cell adhesion to extracellular matrix: Local effects of acute phase reactants. Int Arch Allergy Immunol 1997; 113: 295–296
  • Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe D D, Mekori Y A. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Amer J Physiol-Cell Physiol 1997; 42: C179–C187
  • Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glyco-proteins and induces the adhesion of resting CD4(+) T cells. J Immunol 1996; 156: 1189–1195
  • Peristeris P, Gaspar A, Gros P, Laurent P, Bernon H, Bienvenu J. Effects of Serum Amyloid-A Protein on Lymphocytes, HeLa, and Mrc5 Cells in Culture. Biochem Cell Biol 1989; 67: 365–370
  • Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R., Lider O, Fridkin M. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A-Toward understanding the physiological role of an enigmatic protein. Eur J Biochem 1994; 223: 35–42
  • Zimlichman S, Danon A, Nathan 1, Mozes G, Shainkin-Kestenbaum R. Serum Amyloid-A, an Acute Phase Protein, Inhibits Platelet Activation. J Lab Clin Med 1990; 116: 180–186
  • Linke R P, Bock V, Valet G, Rothe G. Inhibition of the Oxidative Burst Response of N-Formyl Peptide-Stimu-lated Neutrophils by Serum Amyloid-A Protein. Biochem Biophys Res Commun 1991; 176: 1100–1105
  • Sack G H, Talbot C C. The Human Serum Amyloid-A (SAA)-Encoding Gene Gsaal-Nucleotide Sequence and Possible Autocrine-Collagenase-Inducer Function. Gene 1989; 84: 509–515
  • Mitchell T I, Coon C I, Brinckerhoff C E. Serum Amyloid-A (SAA3) Produced by Rabbit Synovial Fibroblasts Treated with Phorbol Esters or Interleukin-1 Induces Synthesis of Collagenase and Is Neutralized with Specific Anti-serum. J CIin Invest 1991; 87: 1177–1185
  • Pruzanski W, de Beer F C, de Beer M C, Stefanski E, Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A(2). Biochem J 1995; 309: 461–464
  • Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart J C. Influence of Serum Amyloid-A on Cholesterol Es-terification in Human Plasma. Biochim Siophys Acta 1989; 1006: 173–178
  • Mindham M A, Mayes P A, Miller N E. Reverse cholesterol transport in the isolated perfused rat spleen. Biochem J 1990; 268: 499–505
  • Mindham M A, Mayes P A. Reverse Cholesterol Transport in the Rat-Studies IJsing the Isolated Perfused Spleen in Con-junction with the Perfused Liver. Biochem J 1991; 279: 503–508
  • Kisilevsky R. Serum Amyloid-A (SAA). a Protein Without a Function-Some Suggestions with Reference to Cholesterol Metabolism. Med Hypotheses 1991; 35: 337–341
  • Kisilevsky R, Lindhorst E, Ancsin J B, Young D, Bagshaw W. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: A hypothesis. Amyloid 1996; 3: 252–260
  • Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997; 1339: 143–154
  • Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function. Lab Invest 1992; 66: 778–785
  • Banka C, Yuan L., De T., Beer M C, Kindy M, Curtiss L K, de Beer F C. Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995; 36: 1058–1065
  • Loivell C A, Potter D A, Stearman R S, Morrow J F. Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem 1986; 261: 8442–8452
  • De Beer M C, de Beer F C, McCubbin W D, Kay C M, Kindy M S. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993; 268: 20606–20612
  • Ancsin J B, Kisilevsky R. The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 1999; 274: 7172–7181
  • Ancsin J B, Kisilevsky R. Laminin interactions with the apoproteins of acute-phase HDL: preliminary mapping of the laminin binding site on serum amyloid A. Amyloid 1999; 6: 37–47
  • Strachan A F, de Beer F C, van der Westhuyzen D R, Coetzee G A. Identification of three isoform patterns of human serum amyloid A protein. Biochem J 1988; 5250: 203–207
  • Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Fohn phenol reagent. J Biol Chem 1951; 193: 265–275
  • Ailain C C, Poon L S, Chan C SG, Richmond W, Fu P C. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470–475
  • Erickson S K, Shrewsbury A, Brooks C, Meyer D J. Rat liver acyl-coenzyme A:cholesterol acyl transferase: its regulation in-vivo and some of its properties in-vitro. J Lipid Res 1980; 21: 930–941
  • Doolittle G M, Chang T. Solubilization, partial purification, and reconstitution in phosphatidylcholine-cho-lesterol liposomes of acyl-CoA:cholesterol acyl transferase. Biochemistty 1982; 21: 674–679
  • Okwu A K, Xu X, Shiratori Y, Tabas I. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyl transferase stimulation in macrophages by cellular sphingomyelin. J Lipid Res 1994; 35: 644–655
  • Brown M S, Dana S E, Goldstein J L. Cholesterol ester formation in cultured human fibroblasts. J Biol Chem 1975; 250: 4025–4027
  • Smith J L, de Jersey J, Pillay S P, Hardie I R. Hepatic acyl-CoA:cholesterol acyl transferase. Development of a standard assay and determination in patients with gall stones. Clin Chim Acta 1986; 158: 271–282
  • Folch J, Lees M, Sloan-Stanley G H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497–509
  • Goldstein J L, Dana S E, Brown M S. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 1974; 71: 4288–4292
  • Su S B, Gong W H, Gao J L, Shen W P, Murphy P M, Oppenheim J J, Wang J M. A seven-transmembrane. G protein-coupled receptor, FPRLl, mediates the chemotac-tic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999; 189: 395–402
  • Le Y Y, Gong W H, Li B Q, Dunlop N M, Shen W P, Su S B, Ye R D, Wang J M. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like I and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 1999; 163: 6777–6784
  • Art1 A, Marsche G, Lestavel S, Sattler W, Malle E. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 2000; 20: 763–772
  • Hayat S, Raynes J G. Acute phase serum amyloid a protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line. Scand J Immunol 2000; 51: 141–146
  • Chronopoulos S, Laird D W, Ali-Khan Z. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: Confocal and irnmunogold electron microscopic studies. J Pathol 1994; 173: 361–369
  • Chronopoulos S, Chan S L, Ratcliffe M JH, Ali-Khan Z. Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes: A double immunogold electron microscopic study. Amyloid 1995; 2: 191–194
  • Rocken C, Kisilevsky R. Binding and endocyto-sis of high density lipoprotein from healthy (HDL) and inflammed (HDLsaa) donors by murine macrophages in-vitro. A light and electronmicroscopic investigation. Amyloid 1997; 4: 259–273
  • Liang J S, Sipe J D. Recombinant human serum amyloid A (apoSAA(p)) binds cholesterol and modulates cholesterol flux. J Lipid Res 1995; 36: 37–46
  • Liang J S, Schreiber B M, Salmona M, Phillip G, Gonnerman W A, de Beer F C, Sipe J D. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 1996; 37: 2109–2116
  • Small C A, Goodacre J A, Yeaman S J. Hormone-sensitive lipase is responsible for the neutral cholesterol ester hydrolase activity in macrophages. FEBS Lett 1989; 247: 205–208
  • Liang J, Elliott-Bryant R, Hajri T, Sipe J D, Cathcart E S. A unique amyloidogenic apolipoprotein serum amyloid A (apoSAA) isoform expressed by the amyloid resistant CE/J mouse strain exhibits higher affinity for macrophages than apoSAA(1) and apoSAA(2) expressed by amyloid susceptible CBA/J mice. Biochim Siophys Acta 1998; 1394: 121–126
  • Martinez M J, Hernandez M L, Lacort M, Ochoa B. Regulation of rat liver microsomal cholesterol ester hydrolase by reversible phosphorylation. Lipids 1994; 29: 7–13
  • Small C A, Rogers M P, Goodacre J A, Yeaman S J. Phosphorylation and activation of hormone-sensitive lipase in isolated macrophages. FEBS Lett 1991; 279: 323–326
  • Segrest J P, Pownall H J, Jackson R L, Glenner G G, Pollock P S. Amyloid A: Amphipathic helixes and lipid binding. Biochemistry 1976; 15: 3187–3191
  • Miura S, Chiba T, Mochizuki N, Nagura H, Nemoto K, Tomita I, Ikeda M, Tomita T. Cholesterol-mediated changes of neutral cholesterol esterase activity in macrophages-Mechanism for mobilization of cholesteryl esters in lipid droplets by HDL. Arterioscler Thromb Vasc Biol 1997; 17: 3033–3040
  • Benson M D, Dwulet F E, DiBartola S P. Identification and characterization of amyloid protein AA in spontaneous canine amyloidosis. Lab Invest 1985; 52: 448–452
  • Benson M D, DiBartola S P, Dwulet F E. A unique insertion in the primary structure of bovine amyloid AA protein. JLab Clin Med 1989; 113: 67–72
  • Erken E, Gray M, Cohen A S, Skinner M. Sequence analysis of amyloid protein AA from a Turkish patient with familial Mediterranean fever-Documentation of its SAA(1 alpha) derivation. Amyloid 1996; 3: 173–176
  • Johnson K H, Sletten K, Munson L, Obrien T D, Papendick R, Westermark P. Amino acid sequence analysis of amyloid protein A (AA) from cats (captive cheetahs: Acinonyx jubatus) with a high prevalence of AA amyloidosis. Amyloid 1997; 4: 171–177
  • Bell A W, Chan S L, Marcantonio D, Ali-Khan Z. Both murine SAA(1) and SAA(2) yield AA amyloid in alveolar hydatid cyst-infected mice. Scand J Immunol 1996; 43: 173–180
  • Yamada T, Liepnieks J, Benson M D, Kluve-Beckerman B. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin. J Immunol 1996; 157: 901–907

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.